Navigation Links
Allscripts to Announce Fiscal Second Quarter Results on January 8, 2009
Date:12/16/2008

ld cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2007 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at http://www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new in
'/>"/>
SOURCE Allscripts
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
2. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
3. Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform
4. Kindred Healthcare, Nations Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management
5. Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
6. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
7. Allscripts to Announce Second Quarter 2008 Results on August 5th
8. East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians
9. Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program
10. Martin Memorial Health Systems Selects Allscripts for Electronic Health Record and Practice Management
11. HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted compensation ... its 2015 Children’s Hospitals Executive Compensation Survey. This ... and the survey results are exclusive to participants. ... on 60 executive and director level positions, and ... subsidiary children’s hospitals. Additionally, it provided a separate ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... Arnold Fitness EXPO in Columbus, Ohio which ... display booth featuring free samples of its superior products ... fat burner Synedrex. The company will also be giving ... top-of-the-line supplements and miniature action figures of its iconic ...
(Date:3/5/2015)... Indialantic, FL (PRWEB) March 05, 2015 ... sports nutrition products, is pleased to offer reformulated Millennium ... official website, Millennium 500 is a German grade creatine ... muscle hydration, promote muscle recovery, and aid with overall ... occurring compound that acts as a reserve energy source ...
(Date:3/5/2015)... March 05, 2015 Jordan Valley Medical ... as a treatment option for sudden cardiac arrest. When ... rhythm and can detect any life-threatening abnormalities. If an ... the patient before delivering a treatment shock to restore ... Elhaddi of Jordan Valley Medical Center and the Heart ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Kevin Batsford ... by the grips of drug addiction. The siblings frequented ... their habits, and to seek refuge during the night. ... drugs, without consideration for his outward appearance, hygiene, or ... substances. CNY Central reported on Feb. 23rd ...
Breaking Medicine News(10 mins):Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3
... trend in health coverage and destabilization of Michigan,s health ... of economic stimulus package. , ANN ARBOR, Mich., Jan. ... report on healthcare coverage released today by the Center ... Michigan compares well to the country as a whole, ...
... (Jan. 26, 2009) There is hope that the drug ... now does -- slow the progression of a devastating degenerative ... move and function. , Now a new study looking ... patients indicates that people who began the drug earlier continued ...
... get a more aggressive treatment for facial lines, texture ... 26 The Pearl procedure is used for the ... aging to provide a healthy, pearl-like glow. By applying ... the laser concurrently sends heat to the deeper layers ...
... N.J., Jan. 26 IncentOne, the leading provider ... announced today that CIGNA, a global health service ... program with IncentOne,s Health Power(TM) incentive technology solution. ... employees toward improved health and wellness by offering ...
... - for the 18th time! - the venue for ... very enjoyable educational interactive forum. It will be held ... are expected to attend. , "Following on from the ... the format of a combination of state-of-the-art sessions, hands-on ...
... Improve Practice Quality, Interoperability, and Fiscal FitnessTAMPA, Fla., ... of more than a decade of standards-based interoperability, ... version 5.5 integrated electronic health records and practice ... well being of physician practices and their patients. ...
Cached Medicine News:Health News:Center for Healthcare Research & Transformation Releases Cover Michigan - a Report on Healthcare Coverage and Access 2Health News:Center for Healthcare Research & Transformation Releases Cover Michigan - a Report on Healthcare Coverage and Access 3Health News:Patients starting Parkinson's drug rasagiline earlier do better 2Health News:Renaissance Laser & Vein Institute (LaserandVeinclinic.com) 'Pearl Treatment' 2Health News:IncentOne Provides Incentive Solution to CIGNA 2Health News:Interactive virtual training at European Urology Forum in Davos 2Health News:Sage Launches Sage Intergy Version 5.5 Integrated Electronic Health Records and Practice Management System 2Health News:Sage Launches Sage Intergy Version 5.5 Integrated Electronic Health Records and Practice Management System 3Health News:Sage Launches Sage Intergy Version 5.5 Integrated Electronic Health Records and Practice Management System 4
(Date:3/5/2015)... 5, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, announced today that Atlanta ... hospitals for spinal cord injury and brain injury, has ... AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients with ... The Phase 1/2a trial follows the ...
(Date:3/5/2015)... British Columbia , March 5, 2015 ... The ultimate goal in the cancer diagnostics sector is ... tumors before they become disruptive, metastatic and symptomatic. For ... assay has been the holy grail of ... diagnostics have been invented such as ELISA-based assays, molecular ...
(Date:3/4/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... II proof of concept clinical study investigating the ... in the treatment of chronic pruritus in patients ... clinically meaningful improvement from baseline by tradipitant (40.5mm ... 100mm unit Visual Analog Scale (VAS) for itch, ...
Breaking Medicine Technology:Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
... NEW YORK, Sept. 29, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0610984/Top-1000-Pharmaceutical-Manufacturers-Asian.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical ... Plimsoll Publishing Ltd. This ...
... Sept. 28, 2011 Boston Scientific Corporation (NYSE: ... for the Federal Circuit found in favor of the Company ...   In today,s decision, the Court of Appeals ... decision finding that Boston Scientific,s NIR® Stent did not infringe ...
Cached Medicine Technology:Top 1000 Pharmaceutical Manufacturers (Asian) 2Top 1000 Pharmaceutical Manufacturers (Asian) 3Top 1000 Pharmaceutical Manufacturers (Asian) 4Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent 2Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent 3
Hemagglutination slide test for the differential qualitative detection and quantitative determination of infectious mononucleosis and other heterophile antibodies in serum or plasma....
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Medicine Products: